146 related articles for article (PubMed ID: 12775449)
1. Persistence of chromosome aberrations in peripheral lymphocytes from Hodgkin's lymphoma remission patients.
Ryabchenko N; Nasonova V; Antoschina M; Fesenko E; Kondrashova T; Ivanova T; Pavlov V; Ryabikhina N; Terekhova A
Int J Radiat Biol; 2003 Apr; 79(4):251-7. PubMed ID: 12775449
[TBL] [Abstract][Full Text] [Related]
2. Aberrant and multiaberrant (rogue) cells in peripheral lymphocytes of Hodgkin's lymphoma patients after chemotherapy.
Ryabchenko NI; Nasonova VA; Fesenko EV; Kondrashova TV; Antoschina MM; Pavlov VV; Ryabikina NV
Mutat Res; 2006 Oct; 601(1-2):61-70. PubMed ID: 16828123
[TBL] [Abstract][Full Text] [Related]
3. Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers.
M'kacher R; Bennaceur-Griscelli A; Girinsky T; Koscielny S; Delhommeau F; Dossou J; Violot D; Leclercq E; Courtier MH; Béron-Gaillard N; Assaf E; Ribrag V; Bourhis J; Feneux D; Bernheim A; Parmentier C; Carde P
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):465-71. PubMed ID: 17418962
[TBL] [Abstract][Full Text] [Related]
4. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions.
Wu X; Lippman SM; Lee JJ; Zhu Y; Wei QV; Thomas M; Hong WK; Spitz MR
Cancer Res; 2002 May; 62(10):2813-8. PubMed ID: 12019158
[TBL] [Abstract][Full Text] [Related]
5. Persistent genomic instability in peripheral blood lymphocytes from Hodgkin lymphoma survivors.
Salas C; Niembro A; Lozano V; Gallardo E; Molina B; Sánchez S; Ramos S; Carnevale A; Pérez-Vera P; Rivera Luna R; Frias S
Environ Mol Mutagen; 2012 May; 53(4):271-80. PubMed ID: 22434555
[TBL] [Abstract][Full Text] [Related]
6. Chromosome radiation-induced aberrations in patients with Hodgkin's disease. Possible correlation with second malignancy?
Zaccaria A; Barbieri E; Mantovani W; Tura S
Boll Ist Sieroter Milan; 1978 Mar; 57(1):76-83. PubMed ID: 656200
[TBL] [Abstract][Full Text] [Related]
7. [Validity of chromosome analysis and bleomycin sensitivity assay in the prevention of head and neck cancer in Hungary].
Székely G; Remenár E; Kásler M; Bodrog A; Gundy S
Orv Hetil; 2001 Mar; 142(12):611-6. PubMed ID: 11324219
[TBL] [Abstract][Full Text] [Related]
8. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
9. [Karyotype of peripheral blood lymphocytes in patients treated for Hodgkin disease].
Cappelaere P; Lai JL; Caty A; Deminatti M; Demaille MC
Bull Cancer; 1983; 70(1):31-9. PubMed ID: 6839032
[TBL] [Abstract][Full Text] [Related]
10. High incidence of chromosome aberrations after radiochemotherapy for Hodgkin's disease: a report of a case and a review of the literature.
Lalić H; Radosević-Stasić B; Volavsek C
Folia Biol (Praha); 2001; 47(3):101-5. PubMed ID: 11409315
[TBL] [Abstract][Full Text] [Related]
11. Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.
Sieniawski M; Franklin J; Nogova L; Glossmann JP; Schober T; Nisters-Backes H; Diehl V; Josting A
J Clin Oncol; 2007 May; 25(15):2000-5. PubMed ID: 17420510
[TBL] [Abstract][Full Text] [Related]
12. High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy.
Chang JY; Komaki R; Sasaki R; Liao Z; Stevens CW; Lu C; Fossella FV; Allen PK; Cox JD; Spitz MR; Wu X
Clin Cancer Res; 2005 Apr; 11(8):2894-8. PubMed ID: 15837739
[TBL] [Abstract][Full Text] [Related]
13. Analysis of spontaneous and bleomycin-induced chromosome damage in peripheral lymphocytes of long-haul aircrew members from Argentina.
Bolzán AD; Bianchi MS; Giménez EM; Flaqué MC; Ciancio VR
Mutat Res; 2008 Mar; 639(1-2):64-79. PubMed ID: 18164039
[TBL] [Abstract][Full Text] [Related]
14. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
[TBL] [Abstract][Full Text] [Related]
15. Differential mutagen sensitivity of peripheral blood lymphocytes from smokers and nonsmokers: effect of human cytomegalovirus infection.
Albrecht T; Deng CZ; Abdel-Rahman SZ; Fons M; Cinciripini P; El-Zein RA
Environ Mol Mutagen; 2004; 43(3):169-78. PubMed ID: 15065204
[TBL] [Abstract][Full Text] [Related]
16. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
Al-Ali HK; Wittekind C; Niederwieser D
Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864
[TBL] [Abstract][Full Text] [Related]
17. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
18. [Chromosome aberrations induced by bleomycin in the lymphocytes of young and old persons].
Musilová J; Michalová K; Folberová L; Pacovský V
Cas Lek Cesk; 1989 Sep; 128(37):1166-9. PubMed ID: 2478286
[TBL] [Abstract][Full Text] [Related]
19. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
20. Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients.
Gergely L; Aleksza M; Váróczy L; Ponyi A; Sipka S; Illés A; Szegedi G
Eur J Haematol; 2004 May; 72(5):336-41. PubMed ID: 15059068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
